BlackRock’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121M | Sell |
|
|||||
|
2025
Q1 | $147M | Buy |
|
|||||
|
2024
Q4 | $140M | Buy |
|
|||||
|
2024
Q3 | $106M | Sell |
|
|||||
|
2024
Q2 | $62.8M | Sell |
|
|||||
|
2024
Q1 | $60.1M | Sell |
|
|||||
|
2023
Q4 | $71.2M | Buy |
|
|||||
|
2023
Q3 | $68.2M | Buy |
|
|||||
|
2023
Q2 | $109M | Buy |
|
|||||
|
2023
Q1 | $136M | Buy |
|
|||||
|
2022
Q4 | $107M | Buy |
|
|||||
|
2022
Q3 | $112M | Buy |
|
|||||
|
2022
Q2 | $109M | Buy |
|
|||||
|
2022
Q1 | $116M | Sell |
|
|||||
|
2021
Q4 | $140M | Sell |
|
|||||
|
2021
Q3 | $111M | Sell |
|
|||||
|
2021
Q2 | $72.8M | Buy |
|
|||||
|
2021
Q1 | $121M | Buy |
|
|||||
|
2020
Q4 | $132M | Buy |
|
|||||
|
2020
Q3 | $87.5M | Buy |
|
|||||
|
2020
Q2 | $91.6M | Buy |
|
|||||
|
2020
Q1 | $63.3M | Sell |
|
|||||
|
2019
Q4 | $61.7M | Buy |
|
|||||
|
2019
Q3 | $45.6M | Buy |
|
|||||
|
2019
Q2 | $78.3M | Buy |
|
|||||
|
2019
Q1 | $80.7M | Sell |
|
|||||
|
2018
Q4 | $82.2M | Buy |
|
|||||
|
2018
Q3 | $100M | Sell |
|
|||||
|
2018
Q2 | $95.8M | Buy |
|
|||||
|
2018
Q1 | $73M | Sell |
|
|||||
|
2017
Q4 | $70M | Sell |
|
|||||
|
2017
Q3 | $83.5M | Buy |
|
|||||
|
2017
Q2 | $64.1M | Buy |
|
|||||
|
2017
Q1 | $57.9M | Buy |
|
|||||
|
2016
Q4 | $252K | Buy |
|
|||||
|
2016
Q3 | $262K | Sell |
|
|||||
|
2016
Q2 | $233K | Buy |
|
|||||
|
2016
Q1 | $31K | Buy |
|
|||||
|
2015
Q4 | $34K | Buy |
|
|||||
|
2015
Q3 | $20K | Buy |
|
|||||
|
2015
Q2 | $28K | Buy |
|
|||||
|
2015
Q1 | $17K | Buy |
|
|||||
|
2014
Q4 | $7K | Hold |
|
|||||
|
2014
Q3 | $5K | Hold |
|
|||||
|
2014
Q2 | $6K | Buy |
|
|||||
|
2014
Q1 | $11K | Buy |
|